Stepan Posts Q3 Adjusted EPS of 94c as Sales Jump 17%
SCL sits 55% above its 52-week low of $41.82 on elevated volume (2.0× avg).
Summary
Stepan reported Q3 adjusted EPS of $0.94, with net sales up 17% to $692.2M and adjusted EBITDA up 18% to $66.3M. That is a clear step up from a first half weighed down by $70.5M in restructuring charges and a Q1 loss, and it extends the Q2 rebound in organic volume, mix and pricing. The stock is trading near its 52-week high of $68, so the bar was already elevated; a 17% sales gain with margin expansion supports the recovery story. The 8-K filed this morning carries the same figures. Stepan also expects full-year adjusted EBITDA growth and positive free cash flow.
At the time of this announcement, SCL was trading at $64.70 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $41.82 to $68.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.